Company: IMNN
Filing Date: 2025-06-09
Form Type: DEF 14A
Source: 0001641172-25-014324
Chunk: 26

Company: Imunon, Inc.
Filing Date: 2025-06-09
Form: DEF 14A
Chunk 26
---
 |      | 0 |
| Alaskan Native or Native American       |     |        | 0 |     |      | 0 |
| Asian                                   |     |        | 0 |     |      | 0 |
| Hispanic or Latinx                      |     |        | 0 |     |      | 0 |
| Native Hawaiian or Pacific Islander     |     |        | 0 |     |      | 0 |
| White                                   |     |        | 2 |     |      | 4 |
| Two or More Races or Ethnicities        |     |        | 0 |     |      | 0 |
| LGBTQ+                                  |     |        | 0 |     |      |   |
| Did Not Disclose Demographic Background |     |        | 0 |     |      |   |

Director Independence

In accordance with the rules of the SEC and Nasdaq, the Company requires that at least a majority of the directors serving at any time on the Board of Directors be independent, that at least three directors satisfy the financial literacy requirements for service on the Audit Committee and that at least one member of the Audit Committee qualify as an “audit committee financial expert” under those rules.

Mr. Dentzer acts as the chairman of our Audit Committee. The Board has determined that Mr. James E. Dentzer is qualified to serve as the “audit committee financial expert” as defined by Item 407(d)(5) of Regulation S-K and that Mr. Fritz and Ms. Pellizzari meet the financial literacy requirements under applicable SEC and Nasdaq rules. The Board of Directors determined that of the six currently serving directors, four directors (Dr. Braun, Messrs. Dentzer and Fritz and Ms. Pellizzari) are independent under applicable SEC and Nasdaq rules.

| 20 |

Nominating and Governance Committee Process

In selecting candidates for our Board of Directors, the Nominating and Governance Committee begins by determining whether the incumbent directors whose terms expire at the annual meeting of stockholders desire and are qualified to continue their service on our Board of Directors. Under its charter, our Nominating and Governance Committee is charged with considering incumbent directors as if they were new candidates. However, our Nominating and Governance Committee recognizes the significant value of the continuing service of qualified incumbents in promoting stability and continuity, providing the benefit of the familiarity and insight into our affairs and enhancing our Board of Directors’ ability to work as a collective body. Therefore, it is the policy of